Bank of New York Mellon Corp - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 70 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$469,186
-17.0%
272,783
-5.9%
0.00%
Q2 2023$565,375
+314.8%
289,936
+491.3%
0.00%
Q1 2023$136,312
-19.4%
49,0330.0%0.00%
Q4 2022$169,164
+34.3%
49,033
-0.3%
0.00%
Q3 2022$126,000
+1.6%
49,165
-3.9%
0.00%
Q2 2022$124,000
-81.2%
51,185
-68.0%
0.00%
Q1 2022$658,000
-67.5%
159,854
+1.6%
0.00%
Q4 2021$2,023,000
+17.5%
157,348
-1.3%
0.00%
Q3 2021$1,722,000
+41.7%
159,374
+19.7%
0.00%
Q2 2021$1,215,000
+14.1%
133,112
+17.8%
0.00%
Q1 2021$1,065,000
+205.2%
112,970
+27.4%
0.00%
Q4 2020$349,000
+43.6%
88,648
-3.6%
0.00%
Q3 2020$243,000
-60.2%
91,969
+0.1%
0.00%
Q2 2020$611,000
+27.8%
91,897
+12.0%
0.00%
Q1 2020$478,000
-35.0%
82,082
+0.2%
0.00%
Q4 2019$735,000
+8.1%
81,902
+3.9%
0.00%
Q3 2019$680,000
-23.6%
78,791
-1.3%
0.00%
Q2 2019$890,000
+204.8%
79,862
+264.0%
0.00%
Q1 2019$292,00021,9380.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders